LBLT

Lattice Biologics Ltd. Stock Price

OTCPK:LBLT.F Community·US$128.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LBLT.F Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

LBLT.F Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Lattice Biologics Ltd. Key Details

US$1.6m

Revenue

US$912.4k

Cost of Revenue

US$645.6k

Gross Profit

US$1.6m

Other Expenses

-US$951.7k

Earnings

Last Reported Earnings
Jun 30, 2021
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About LBLT.F

Founded
n/a
Employees
n/a
CEO
n/a
Website
n/a

Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company is headquartered in Belgrade, Montana.

Recent LBLT.F News & Updates

No updates

Recent updates

No updates